Venturi Wealth Management LLC lessened its position in shares of DocuSign, Inc. (NASDAQ:DOCU - Free Report) by 61.6% in the 4th quarter, according to its most recent 13F filing with the Securities and Exchange Commission (SEC). The institutional investor owned 2,583 shares of the company's stock after selling 4,139 shares during the quarter. Venturi Wealth Management LLC's holdings in DocuSign were worth $232,000 as of its most recent SEC filing.
Several other institutional investors have also added to or reduced their stakes in DOCU. Creative Planning grew its holdings in DocuSign by 5.6% during the 3rd quarter. Creative Planning now owns 14,453 shares of the company's stock valued at $897,000 after buying an additional 766 shares in the last quarter. Blue Trust Inc. lifted its stake in shares of DocuSign by 1,355.9% in the 3rd quarter. Blue Trust Inc. now owns 1,485 shares of the company's stock valued at $92,000 after purchasing an additional 1,383 shares during the last quarter. Raymond James & Associates lifted its stake in shares of DocuSign by 16.3% in the 3rd quarter. Raymond James & Associates now owns 166,406 shares of the company's stock valued at $10,332,000 after purchasing an additional 23,269 shares during the last quarter. Allspring Global Investments Holdings LLC lifted its stake in shares of DocuSign by 2,194.6% in the 3rd quarter. Allspring Global Investments Holdings LLC now owns 105,688 shares of the company's stock valued at $6,562,000 after purchasing an additional 101,082 shares during the last quarter. Finally, International Assets Investment Management LLC lifted its stake in shares of DocuSign by 5,660.8% in the 3rd quarter. International Assets Investment Management LLC now owns 438,914 shares of the company's stock valued at $27,252,000 after purchasing an additional 431,295 shares during the last quarter. Hedge funds and other institutional investors own 77.64% of the company's stock.
In other DocuSign news, CEO Allan C. Thygesen sold 7,763 shares of DocuSign stock in a transaction on Monday, December 2nd. The stock was sold at an average price of $80.54, for a total transaction of $625,232.02. Following the completion of the sale, the chief executive officer now directly owns 100,062 shares of the company's stock, valued at $8,058,993.48. The trade was a 7.20 % decrease in their position. The sale was disclosed in a document filed with the SEC, which is available at this hyperlink. Also, insider Robert Chatwani sold 14,800 shares of DocuSign stock in a transaction on Wednesday, December 18th. The shares were sold at an average price of $97.76, for a total value of $1,446,848.00. Following the sale, the insider now directly owns 73,414 shares of the company's stock, valued at approximately $7,176,952.64. This trade represents a 16.78 % decrease in their ownership of the stock. The disclosure for this sale can be found here. Insiders sold a total of 693,773 shares of company stock valued at $66,727,926 in the last ninety days. Corporate insiders own 1.66% of the company's stock.
Several equities research analysts have recently issued reports on DOCU shares. Royal Bank of Canada reaffirmed a "sector perform" rating and issued a $90.00 price objective (up from $57.00) on shares of DocuSign in a research note on Friday, December 6th. Jefferies Financial Group raised their price objective on DocuSign from $80.00 to $95.00 and gave the company a "buy" rating in a research note on Tuesday, December 3rd. JPMorgan Chase & Co. raised their price objective on DocuSign from $50.00 to $70.00 and gave the company an "underweight" rating in a research note on Tuesday, December 3rd. Piper Sandler raised their price objective on DocuSign from $60.00 to $90.00 and gave the company a "neutral" rating in a research note on Friday, December 6th. Finally, JMP Securities reaffirmed a "market outperform" rating and issued a $124.00 price objective on shares of DocuSign in a research note on Tuesday, January 7th. Three equities research analysts have rated the stock with a sell rating, seven have issued a hold rating and three have given a buy rating to the company. According to data from MarketBeat, the stock currently has a consensus rating of "Hold" and an average target price of $92.45.
View Our Latest Report on DocuSign
Shares of NASDAQ DOCU opened at $83.96 on Friday. The business has a fifty day simple moving average of $91.94 and a two-hundred day simple moving average of $76.27. The firm has a market cap of $16.96 billion, a PE ratio of 17.31, a price-to-earnings-growth ratio of 6.98 and a beta of 0.89. DocuSign, Inc. has a twelve month low of $48.70 and a twelve month high of $107.86.
DocuSign, Inc provides electronic signature solution in the United States and internationally. The company provides e-signature solution that enables sending and signing of agreements on various devices; Contract Lifecycle Management (CLM), which automates workflows across the entire agreement process; Document Generation streamlines the process of generating new, custom agreements; and Gen for Salesforce, which allows sales representatives to automatically generate agreements with a few clicks from within Salesforce.
This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest and most accurate reporting. This story was reviewed by MarketBeat's editorial team prior to publication. Please send any questions or comments about this story to [email protected].
Before you consider DocuSign, you'll want to hear this.
MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and DocuSign wasn't on the list.
While DocuSign currently has a "Hold" rating among analysts, top-rated analysts believe these five stocks are better buys.